© 2000 by European Society of Cardiology
ATRIAL ARRHYTHMIAS
Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing
Centre Chirurgical Val D'Or Saint-Cloud, France
Abstract
AIMS: The effectiveness of atrial pacing in reducing the incidence of atrial fibrillation in patients with sinus node dysfunction is incomplete, and the correlation between electrophysiological atrial properties and the effect of permanent atrial pacing has been poorly investigated. Accordingly, the aim of the present study was to correlate electrophysiological data, in terms of atrial refractoriness, conduction parameters, and propensity to atrial fibrillation induction, and the likelihood of atrial fibrillation after DDD device implantation.
METHODS AND RESULTS: The authors reviewed electrophysiological data of 41 patients with sinus node dysfunction (mean age 70±8 years, who were investigated free of antiarrhythmic treatments before pacemaker implantation. At a drive cycle length of 600 ms, effective and functional refractory periods, S1–A1 and S2–A2 latency, A1 and A2 width, and latent vulnerability index (effective refractory period [ERP] A2), were measured. Atrial fibrillation induction was tested with up to three extrastimuli in 34 patients. Induction of sustained atrial fibrillation (>1 min) was considered as the end-point. P-wave duration on the surface ECG in lead II/V1 was also measured. Minimal atrial rate was programmed between 60 and 75 bpm (mean: 64±4 bpm). After implantation, the patients were followed-up for 28±17 months, and ECG-documented occurrence of atrial fibrillation was determined. Electrophysiological characteristics of patients with (n=12) or without (n=29) paroxysmal atrial fibrillation before implantation were similar. When comparing patients with (n=11) or without (n=30) post-pacing atrial fibrillation occurrence, no differences were found in age, underlying heart disease, left atrial size, minimal pacing rate, and follow-up duration. Additionally, between the two former groups, there was no significant difference in terms of effective refractory periods (233±47 ms vs 239±25 ms), functional refractory periods (280±48 ms vs 272±21 ms), S1–A1 (44±20 ms vs 37±13 ms) and S2–A2 latency (77±28 ms vs 66±22 ms), and A1 duration (60±23 ms vs 53±16 ms). In contrast, in patients with post-pacing atrial fibrillation occurrence, the P wave was more prolonged (116±22 ms vs 98±13 ms;P< 0·01), A2 was longer (116±41 ms vs 87±27 ms;P< 0·01), effective refractory periods/A2 was lower (2·1±0·4 cm vs 3·1±1·4 cm;P< 0·05), and rate of atrial fibrillation induction was higher (8/11 patients vs 8/23 patients;P< 0·05). Electrophysiological characteristics of patients free of post-pacing atrial fibrillation with associated (n=6) or unassociated (n=24) paroxysmal atrial fibrillation history before implantation were quite similar. In patients with post-pacing atrial fibrillation with associated (n=6) or unassociated atrial fibrillation history (n=5) before implantation, effective refractory periods was statistically different (207±23 ms vs 264±46 ms;P< 0·05). Values of effective refractory periods <220 ms were significantly more frequent in patients with post-pacing atrial fibrillation than in patients without (4/11 patients vs 2/30 patients;P< 0·05). When comparing patients with post-pacing atrial fibrillation with effective refractory periods 
220 ms (n=7) and <220 ms (n=4), A2 duration was remarkably prolonged (145±42 ms vs 90±11 ms;P< 0·05) in those with effective refractory periods 220 ms. By contrast, between the two groups, effective refractory periods/A2 were identical (2·08±0·6 cm vs 2·15±0·3 cm;P=n.s.).
CONCLUSION: Prolonged atrial refractoriness, lesser degrees of conduction disturbance and a lower rate of atrial fibrillation induction seem to be predictive of stable sinus rhythm. In contrast, patients with persistence of atrial fibrillation despite pacing have a more abnormal and inhomogeneous atrial substrate, as well as a higher rate of atrial fibrillation induction.
Prolonged P wave, shortened refractoriness, or remarkably abnormal conduction disturbances in the presence of prolonged refractoriness limit the effectiveness of standard atrial pacing in atrial fibrillation prevention. Identification of predictive criteria of failure of single-site atrial pacing may be used to consider dual-site atrial pacing in such patients with sinus node dysfunction.
Key Words: Sinus node dysfunction, atrial fibrillation, electrophysiological study, atrial pacing
Correspondence: A. De Sisti, Centre Chirurgical Val D'Or, 16 rue Pasteur 92210, Saint-Cloud, France.
References
[1] Rosenqvist M, Brandt J, Schüller H. Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988; 116: 16–22.[CrossRef][Web of Science][Medline]
[2] Stangl K, Seitz K, Wirtzfeld A, et al. Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome. Pacing Clin Electrophysiol 1990; 13: 2080–2085.[Medline]
[3] Brandt J, Anderson H, Fåhraeus T, et al. Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode. J Am Coll Cardiol 1992; 20: 633–639.[Abstract]
[4] Andersen HR, Thuesen L, Bagger JP, et al. Prospective randomized trial of atrial vrsus ventricular pacing in sick sinus syndrome. Lancet 1994; 344: 1523–1528.[CrossRef][Web of Science][Medline]
[5] Daubert JC, Leclercq C, Parin D. Biatrial synchronous pacing: a new approach to prevent arrhythmias in patients with atrial conduction block. In Daubert JC, Prystowsky EN, Ripart A (Eds.). Prevention of Tachyarrhythmias with Cardiac Pacing 1997; Armonk Futura Publishing Co., Inc 99–119.
[6] Saksena S, Prakash A, Hill M, et al. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 1996; 28: 687–694.[Abstract]
[7] Attuel P, Pellerin D, Gaston J. Latent atrial vulnerability: new means of electrophysiologic investigations in paroxysmal atrial arrhythmias. In Attuel P, Coumel P, Janse M (Eds.). The Atrium in Health and Disease 1989; Mount Kisco Futura Publishing Co., Inc 159–200.
[8] Sutton R and Kenny RA. The natural history of sick sinus syndrome. Pacing Clin Electrophysiol 1986; 9: 1110–1114.[CrossRef][Medline]
[9] Coumel P, Friocourt P, Mugica J, et al. Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90/minute: experience with 6 cases. Pacing Clin Electrophysiol 1983; 6: 552–560.[CrossRef][Medline]
[10] Attuel P, Pellerin D, Mugica J, et al. DDD pacing: an effective treatment modality for recurrent atrial arrhythmias. Pacing Clin Electrophysiol 1988; 11: 237–242.
[11] Han J, Milled D, Chizzonitti B, et al. Temporal dispersion of recovery of exitability in atrium and ventricle as a function of heart rate. Am Heart J 1996; 71: 481–487.
[12] Centurion OA, Isomoto S, Fukatani M, et al. Relationship between atrial conduction defects and fractioned atrial endocardial electrograms in patients with sick sinus syndrome. Pacing Clin Electrophysiol 1993; 16: 2022–2033.[CrossRef][Medline]
[13] Ohe To, Matsuhisa M, Kamakura S, et al. Relation between widening of fragmented atrial activity zone and atrial fibrillation. Am J Cardiol 1983; 52: 1229–1232.[CrossRef]
[14] Tanigawa M, Fukatani M, Konoe A, et al. Prolonged and fractionated atrial electrograms durin sinus rhythm in papients with paroxysmal atrial fibrillation and sick sinus node syndrome. J Am Coll Cardiol 1991; 17: 403–408.[Abstract]
[15] Luck JC and Engel TR. Dispersion of refractoriness in patients with sinus node dysfunction. Circulation 1997; 2: 404–412.
[16] De Sisti A, Leclercq JF, Fiorello P, et al. Electrophysiological characteristics of the atrium in sinus node dysfunction: atrial refractoriness and conduction characteristics. J Cardiovasc Electrophysiol 2000; 11: 30–33.[Web of Science][Medline]
[17] Centurion OA, Fukatani M, Konoe A, et al. Different distribution of abnormal endocardial electrograms within the rigth atrium in patients with sick sinus syndrome. Br Heart J 1992; 68: 596–600.
[18] De Sisti A, Leclercq JF, Fiorello P, et al. Value of sinus P-wave duraion in predicting the natural history of patients with atrial fibrillation and DDD pacemaker (Abstr). Pacing Clin Electrophysiol 2000; 23: 743.
[19] Allessie MA, Lammers WJEP, Bonke FIM, et al. Experimental evaluation of Moe's multiple wavelets hypothesis of atrial fibrillation. In Zipes DP and Jalife J (Eds.). Cardiac Electrophysiology and Arrhythmias 1985; San Diego Grune & Stratton 265–272.
[20] Bayes de Luna A, Cladellas M, Oter R, et al. Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhytmia. Eur Heart J 1988; 9: 1112–1118.
[21] Simpson RJ, Foster JR, Gettes LS. Atrial excitability and conduction in patients with interatrial conduction defects. Am J Cardiol 1982; 50: 1331–1337.[CrossRef][Web of Science][Medline]
[22] Stabile G, Senatore G, De Simone A, et al. Determinants of efficacy of atrial pacing in preventing atrial fibrillation recurrences. J Cardiovasc Electrophysiol 1999; 10: 2–9.[Web of Science][Medline]
[23] Page RL, Wilkinson WE, Clair WK, et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994; 89: 224–227.
[24] Kanji I, Chisato I, Atsushi N, et al. Problems in pharmacological evaluation of patients with paroxysmal atrial fibrillation: clinical analysis of more than 100 consecutive patients. Int Med 1998; 37: 1005–1008.
[25] Swiryn S, Schoenwald AT, Sahakian AV. Detection of atrial fibrillation by pacemakers and antiarrhythmic devices. In Murgatroyd FD and Camm AJ (Eds.). Non Pharmacological Management of Atrial Fibrillation 1991; Armonk Futura Publishing Company, Inc 309–318.
[26] Papageorgiou P, Anselme F, Kirchhof CJHJ. Coronary sinus pacing prevents induction of atrial fibrillation. Circulation 1997; 96: 1893–1898.
[27] Yu WC, Chen SA, Tai CT, et al. Effects of different atrial pacing modes on atrial electrophysiology. Circulation 1997; 96: 2992–2996.[Medline]
[28] Prakash A, Delfaut P, Krol RB. Regional right and left atrial activation patterns during single- and dual-site atrial pacing in patients with atrial fibrillation. Am J Cardiol 1998; 82: 1197–1204.[CrossRef][Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||